查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
羊膜產品市場 - 全球規模、佔有率、趨勢分析、機會、預測報告，2019-2030
市場調查報告書
商品編碼
1410992

羊膜產品市場 - 全球規模、佔有率、趨勢分析、機會、預測報告，2019-2030

Amniotic Products Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2030, Segmented By Type ; By End User ; By Application ; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

至2030年，全球羊膜產品市場規模將超過13億美元，2024年至2030年複合年成長率為8.56%

由於人們對羊膜產品的好處的認知不斷提高以及對羊膜產品研發的投資不斷增加，全球羊膜產品市場正在受到越來越多的關注。

領先的策略諮詢和市場研究公司 BlueWeave Consulting 在最近的一項研究中估計，2023 年全球羊膜產品市場規模將達到 8.104 億美元。 BlueWeave預測，在2024年至2030年的預測期內，全球羊膜產品市場規模將以8.56%的複合年成長率成長，到2030年將達到13.262億美元。羊膜產品在皮膚和眼部疾病治療中的使用增加以及潰瘍等慢性傷口發病率的增加是全球羊膜產品市場的關鍵促進因素。此外，增加有關羊膜產品的研發計劃預計將在分析期間推動市場成長。

該報告的詳細分析提供了有關成長潛力、未來趨勢和全球羊膜產品市場的資訊。它還揭示了推動市場總規模預測的因素。該報告提供了全球羊膜產品市場的最新技術趨勢和業界考察，並承諾幫助決策者做出明智的策略決策。它還分析了市場成長促進因素、挑戰和競爭動態。

目錄

第1章 研究框架

第 2 章執行摘要

第3章 全球羊膜產品市場洞察

  • 產業價值鏈分析
  • DROC分析
    • 生長促進因子
      • 慢性傷口盛行率增加
      • 提高人們對羊膜產品益處的認知
      • 加大羊膜產品研發投入
    • 抑制因素
      • 羊膜的可得性有限
      • 來自替代傷口護理產品的競爭
    • 機會
      • 擴大再生醫學的應用
      • 新興市場需求不斷成長
    • 任務
      • 保持羊膜產品的品質和一致性
      • 對醫療保健專業人員進行羊膜產品的教育
  • 科技進步/最新發展
  • 消費者行為與洞察
  • 法律規範
  • 波特五力分析

第4章 全球羊膜產品市場概況

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 按類型
      • 冷凍保存羊膜
      • 脫水羊膜
    • 按最終用戶
      • 醫院及門診手術中心
      • 其他
    • 按用途
      • 創傷護理
      • 整形外科
      • 眼科
      • 其他
    • 按地區
      • 北美洲
      • 歐洲
      • 亞太地區 (APAC)
      • 拉丁美洲 (LATAM)
      • 中東和非洲 (MEA)

第5章 北美羊膜產品市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 按類型
    • 按最終用戶
    • 按用途
    • 按國家/地區
      • 美國
      • 加拿大

第6章 歐洲羊膜產品市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 按類型
    • 按最終用戶
    • 按用途
    • 按國家/地區
      • 德國
      • 英國
      • 義大利
      • 法國
      • 西班牙
      • 比利時
      • 俄羅斯
      • 荷蘭
      • 其他

第7章亞太羊膜產品市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 按類型
    • 按最終用戶
    • 按用途
    • 按國家/地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 澳洲和紐西蘭
      • 印尼
      • 馬來西亞
      • 新加坡
      • 越南
      • 其他

第8章拉丁美洲羊膜產品市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 按類型
    • 按最終用戶
    • 按用途
    • 按國家/地區
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘魯
      • 其他

第9章中東及非洲羊膜產品市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 按類型
    • 按最終用戶
    • 按用途
    • 按國家/地區
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 科威特
      • 南非
      • 奈及利亞
      • 阿爾及利亞
      • 其他

第10章競爭形勢

  • 主要企業及其產品列表
  • 2023年全球羊膜產品市場佔有率分析
  • 透過管理參數進行競爭基準化分析
  • 主要策略發展（合併、收購、合作夥伴關係等）

第11章地緣政治緊張局勢對全球羊膜產品市場的影響

第12章 公司簡介（公司簡介、財務矩陣、競爭形勢、關鍵人力資源、主要競爭對手、聯絡地址、策略展望、SWOT分析）

  • MiMedx Group
  • Organogenesis
  • Smith &Nephew
  • Integra LifeSciences
  • Amniox Medical
  • AmnioTech
  • Skye Biologics
  • Applied Biologics
  • TissueTech
  • Katena Products
  • 其他主要企業

第13章 關鍵策略建議

第14章調查方法

簡介目錄
Product Code: BWC24030

Global Amniotic Products Market Size Set to Surpass USD 1.3 Billion by 2030, Expanding at CAGR of 8.56% During 2024-2030.

Global Amniotic Products Market is gaining traction because of the growing awareness about the benefits of amniotic products and increasing investments in amniotic product research and development.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Global Amniotic Products Market size at USD 810.4 million in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Global Amniotic Products Market size to grow at a CAGR of 8.56% reaching a value of USD 1,326.2 million by 2030. The increasing use of amniotic products in the treatment of skin and eye conditions, as well as the growing incidence of chronic wounds, such as ulcers, are significant driving factors for the Global Amniotic Products Market. Moreover, over the period in analysis, it is expected that growing number of research and development programs on amniotic products will propel market growth.

Opportunity: Increasing number of amniotic product launches

The rising adoption of amniotic products in the healthcare sector owing to their therapeutic properties is also influencing product launches and research and development programs in the field. For instance, Amnio Technology, a United States-based developer and manufacturer of amnion-derived technologies, announced the launch of two new PalinGen membrane products, PalinGen Dual-Layer Membrane, and Dual Layer PalinGen X-Membrane. Versea Health, Inc., another US-based pharmaceutical products company, is launching Biovance 3L ocular tri-layer human amniotic membrane.

Global Amniotic Products Market - By End User

Based on end user, the Global Amniotic Products Market is segmented into hospitals, ambulatory surgical centers, and others. The hospital segment holds the largest share of the Global Amniotic Products Market by end user. The growth of the segment is mainly attributed to the high number of outpatient visits for wound treatment and surgical procedures. Amniotic membranes are mostly obtained at hospitals for use in tendon and ligament repair or for ophthalmic purposes. Hospital billing and reimbursement for these products are also easily obtained, which is a key factor contributing to the growth of the hospitals segment.

Impact of Escalating Geopolitical Tensions on Global Amniotic Products Market

The escalating geopolitical tensions are negatively impacting the growth of the Global Amniotic Products Market. Ukraine has a flourishing medical tourism sector. The country offers cost-effective quality healthcare. Ukraine's medical sector was increasingly becoming the hub for specialized treatments not readily available in other countries. However, with Russia's war on Ukraine, medical tourism dwindled, and the number of surgeries performed in the country declined at a staggering rate owing to the sensitive situation in the country and a lack of resources. It resulted in a significant decline in the demand for amniotic products for healthcare purposes as well as hindered research and development activities, limiting its market growth.

Global Amniotic Products Market - By Region

The in-depth research report on the Global Amniotic Products Market covers a number of country-specific markets across five major regions: North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa. North America dominates the Global Amniotic Products Market. The rising healthcare expenditure, coupled with the increasing prevalence of chronic wounds and diabetes, as well as the high concentration of amniotic product manufacturers, are directly influencing market growth. However, the Asia Pacific region is projected to register a high growth rate during the forecast period owing to the growing geriatric population in East Asian countries, including Japan and South Korea.

Competitive Landscape

Major players operating in the Global Amniotic Products Market include: MiMedx Group, Organogenesis, Smith & Nephew, Integra LifeSciences, Amniox Medical, AmnioTech, Skye Biologics, Applied Biologics, TissueTech, and Katena Products. These companies employ various strategies to further enhance their market share, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Don't miss the business opportunity in the Global Amniotic Products Market. Consult our analysts to gain crucial insights and facilitate your business growth.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Amniotic Products Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Amniotic Products Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Amniotic Products Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Increasing Prevalence of Chronic Wounds
      • 3.2.1.2. Growing Awareness of the Benefits of Amniotic Products
      • 3.2.1.3. Increasing Investments in Amniotic Product Research and Development
    • 3.2.2. Restraints
      • 3.2.2.1. Limited Availability of Amniotic Membranes
      • 3.2.2.2. Competition from Alternative Wound Care Products
    • 3.2.3. Opportunities
      • 3.2.3.1. Expanding Applications in Regenerative Medicine
      • 3.2.3.2. Growing Demand in Emerging Markets
    • 3.2.4. Challenges
      • 3.2.4.1. Maintaining the Quality and Consistency of Amniotic Products
      • 3.2.4.2. Educating Healthcare Professionals about Amniotic Products
  • 3.3. Technological Advancements/Recent Developments
  • 3.4. Consumer Behavior and Insights
  • 3.5. Regulatory Framework
  • 3.6. Porter's Five Forces Analysis
    • 3.6.1. Bargaining Power of Suppliers
    • 3.6.2. Bargaining Power of Buyers
    • 3.6.3. Threat of New Entrants
    • 3.6.4. Threat of Substitutes
    • 3.6.5. Intensity of Rivalry

4. Global Amniotic Products Market Overview

  • 4.1. Market Size & Forecast, 2019-2030
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share and Forecast
    • 4.2.1. By Type
      • 4.2.1.1. Cryopreserved Amniotic Membrane
      • 4.2.1.2. Dehydrated Amniotic Membrane
    • 4.2.2. By End User
      • 4.2.2.1. Hospitals & Ambulatory Surgical Centers
      • 4.2.2.2. Others
    • 4.2.3. By Application
      • 4.2.3.1. Wound Care
      • 4.2.3.2. Orthopedics
      • 4.2.3.3. Ophthalmology
      • 4.2.3.4. Others
    • 4.2.4. By Region
      • 4.2.4.1. North America
      • 4.2.4.2. Europe
      • 4.2.4.3. Asia Pacific (APAC)
      • 4.2.4.4. Latin America (LATAM)
      • 4.2.4.5. Middle East and Africa (MEA)

5. North America Amniotic Products Market

  • 5.1. Market Size & Forecast, 2019-2030
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type
    • 5.2.2. By End User
    • 5.2.3. By Application
    • 5.2.4. By Country
      • 5.2.4.1. United States
      • 5.2.4.1.1. By Type
      • 5.2.4.1.2. By End User
      • 5.2.4.1.3. By Application
      • 5.2.4.2. Canada
      • 5.2.4.2.1. By Type
      • 5.2.4.2.2. By End User
      • 5.2.4.2.3. By Application

6. Europe Amniotic Products Market

  • 6.1. Market Size & Forecast, 2019-2030
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By End User
    • 6.2.3. By Application
    • 6.2.4. By Country
      • 6.2.4.1. Germany
      • 6.2.4.1.1. By Type
      • 6.2.4.1.2. By End User
      • 6.2.4.1.3. By Application
      • 6.2.4.2. United Kingdom
      • 6.2.4.2.1. By Type
      • 6.2.4.2.2. By End User
      • 6.2.4.2.3. By Application
      • 6.2.4.3. Italy
      • 6.2.4.3.1. By Type
      • 6.2.4.3.2. By End User
      • 6.2.4.3.3. By Application
      • 6.2.4.4. France
      • 6.2.4.4.1. By Type
      • 6.2.4.4.2. By End User
      • 6.2.4.4.3. By Application
      • 6.2.4.5. Spain
      • 6.2.4.5.1. By Type
      • 6.2.4.5.2. By End User
      • 6.2.4.5.3. By Application
      • 6.2.4.6. Belgium
      • 6.2.4.6.1. By Type
      • 6.2.4.6.2. By End User
      • 6.2.4.6.3. By Application
      • 6.2.4.7. Russia
      • 6.2.4.7.1. By Type
      • 6.2.4.7.2. By End User
      • 6.2.4.7.3. By Application
      • 6.2.4.8. The Netherlands
      • 6.2.4.8.1. By Type
      • 6.2.4.8.2. By End User
      • 6.2.4.8.3. By Application
      • 6.2.4.9. Rest of Europe
      • 6.2.4.9.1. By Type
      • 6.2.4.9.2. By End User
      • 6.2.4.9.3. By Application

7. Asia Pacific Amniotic Products Market

  • 7.1. Market Size & Forecast, 2019-2030
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By End User
    • 7.2.3. By Application
    • 7.2.4. By Country
      • 7.2.4.1. China
      • 7.2.4.1.1. By Type
      • 7.2.4.1.2. By End User
      • 7.2.4.1.3. By Application
      • 7.2.4.2. India
      • 7.2.4.2.1. By Type
      • 7.2.4.2.2. By End User
      • 7.2.4.2.3. By Application
      • 7.2.4.3. Japan
      • 7.2.4.3.1. By Type
      • 7.2.4.3.2. By End User
      • 7.2.4.3.3. By Application
      • 7.2.4.4. South Korea
      • 7.2.4.4.1. By Type
      • 7.2.4.4.2. By End User
      • 7.2.4.4.3. By Application
      • 7.2.4.5. Australia & New Zealand
      • 7.2.4.5.1. By Type
      • 7.2.4.5.2. By End User
      • 7.2.4.5.3. By Application
      • 7.2.4.6. Indonesia
      • 7.2.4.6.1. By Type
      • 7.2.4.6.2. By End User
      • 7.2.4.6.3. By Application
      • 7.2.4.7. Malaysia
      • 7.2.4.7.1. By Type
      • 7.2.4.7.2. By End User
      • 7.2.4.7.3. By Application
      • 7.2.4.8. Singapore
      • 7.2.4.8.1. By Type
      • 7.2.4.8.2. By End User
      • 7.2.4.8.3. By Application
      • 7.2.4.9. Vietnam
      • 7.2.4.9.1. By Type
      • 7.2.4.9.2. By End User
      • 7.2.4.9.3. By Application
      • 7.2.4.10. Rest of APAC
      • 7.2.4.10.1. By Type
      • 7.2.4.10.2. By End User
      • 7.2.4.10.3. By Application

8. Latin America Amniotic Products Market

  • 8.1. Market Size & Forecast, 2019-2030
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By End User
    • 8.2.3. By Application
    • 8.2.4. By Country
      • 8.2.4.1. Brazil
      • 8.2.4.1.1. By Type
      • 8.2.4.1.2. By End User
      • 8.2.4.1.3. By Application
      • 8.2.4.2. Mexico
      • 8.2.4.2.1. By Type
      • 8.2.4.2.2. By End User
      • 8.2.4.2.3. By Application
      • 8.2.4.3. Argentina
      • 8.2.4.3.1. By Type
      • 8.2.4.3.2. By End User
      • 8.2.4.3.3. By Application
      • 8.2.4.4. Peru
      • 8.2.4.4.1. By Type
      • 8.2.4.4.2. By End User
      • 8.2.4.4.3. By Application
      • 8.2.4.5. Rest of LATAM
      • 8.2.4.5.1. By Type
      • 8.2.4.5.2. By End User
      • 8.2.4.5.3. By Application

9. Middle East & Africa Amniotic Products Market

  • 9.1. Market Size & Forecast, 2019-2030
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By End User
    • 9.2.3. By Application
    • 9.2.4. By Country
      • 9.2.4.1. Saudi Arabia
      • 9.2.4.1.1. By Type
      • 9.2.4.1.2. By End User
      • 9.2.4.1.3. By Application
      • 9.2.4.2. UAE
      • 9.2.4.2.1. By Type
      • 9.2.4.2.2. By End User
      • 9.2.4.2.3. By Application
      • 9.2.4.3. Qatar
      • 9.2.4.3.1. By Type
      • 9.2.4.3.2. By End User
      • 9.2.4.3.3. By Application
      • 9.2.4.4. Kuwait
      • 9.2.4.4.1. By Type
      • 9.2.4.4.2. By End User
      • 9.2.4.4.3. By Application
      • 9.2.4.5. South Africa
      • 9.2.4.5.1. By Type
      • 9.2.4.5.2. By End User
      • 9.2.4.5.3. By Application
      • 9.2.4.6. Nigeria
      • 9.2.4.6.1. By Type
      • 9.2.4.6.2. By End User
      • 9.2.4.6.3. By Application
      • 9.2.4.7. Algeria
      • 9.2.4.7.1. By Type
      • 9.2.4.7.2. By End User
      • 9.2.4.7.3. By Application
      • 9.2.4.8. Rest of MEA
      • 9.2.4.8.1. By Type
      • 9.2.4.8.2. By End User
      • 9.2.4.8.3. By Application

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global Amniotic Products Market Share Analysis, 2023
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Geopolitical Tension on Global Amniotic Products Market

12. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. MiMedx Group
  • 12.2. Organogenesis
  • 12.3. Smith & Nephew
  • 12.4. Integra LifeSciences
  • 12.5. Amniox Medical
  • 12.6. AmnioTech
  • 12.7. Skye Biologics
  • 12.8. Applied Biologics
  • 12.9. TissueTech
  • 12.10. Katena Products
  • 12.11. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations